Global, Regional, and National Quality of Care Index (QCI) of Gastric Cancer: A Systematic Analysis for the Global Burden of Disease Study 1990-2017

• DOI: 10.1007/s12029-023-00950-3
• Publication Date: 2023-06-27T00:02:22Z
• Authors: Nima Fattahi; Ali Ghanbari; Shirin Djalalinia; Negar Rezaei; Esmaeil Mohammadi; Sina Azadnajafabad; Mohsen Abbasi-Kan...; Armin Aryannejad; Arya Aminorroaya; Nazila Rezaei; Mehrdad Azmin; Rojin Ramezani; Farzane Jafari; Mahdi Aghili; Farshad Farzadfar
• Keywords: Male; Adult; Stomach Neoplasms; Incidence; Prevalence; Humans; Female; Middle Aged; Global Health; 3. Good health; Global Burden of Disease; Quality of Health Care; Aged

Gastric Cancer (GC)is the third leading cause of cancer death worldwide. We aimed to compare the quality of care of GC at global, regional, and national levels from 1990 to 2017 in different age, sex, and socio-demographic groups using the quality-of-care index.METHOD: We used Mortality to Incidence Ratio, DALY to Prevalence Ratio, YLL to YLD Ratio, and Prevalence to Incidence Ratio, that all indicate the quality of care. Then, using Principal Component Analysis (PCA), these values are combined. A new index called QCI (Quality of Care Index), which indicates quality, is introduced to compare the quality of care in different countries in 1990 and 2017. Scores were calculated and scaled 0-100, with higher scores indicating better status.The global QCI of GC in 1990 and 2017 was 35.7 and 66.7, respectively. The QCI index is 89.6 and 16.4 in high and low SDI countries, respectively. In 2017, Japan had the highest QCI with a 100 score. Japan was followed by South Korea, Singapore, Australia, and the United States with 99.5, 98.4, 98.3, and 90.0. On the other hand, the Central African Republic, Eritrea, Papua New Guinea, Lesotho, and Afghanistan with 11.6, 13.0, 13.1, 13.5, and 13.7 had the worst QCI, respectively.The quality of care of GC has increased worldwide from 1990 to 2017. Also, higher SDI was associated with more quality of care. We recommend conducting more screening and therapeutic programs for early detection and to improve gastric cancer treatment in developing countries.